Table 2.

Criteria for pharmacological therapy of obesity [27, 40]

BMI ≥30 without obesity-related risk factors or BMI ≥27 in association with significant obesity-related risk factors

Drugs may only be used as part of a comprehensive weight loss program

Should never be used without concomitant lifestyle modifications

For continued treatment, patients should have a weight loss of ≥4 pounds per month for each of the first 3 months